These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15870547)

  • 1. Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events.
    Pelkonen KM; Wartiovaara-Kautto U; Nieminen MS; Ahonen K; Sinisalo J
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):275-80. PubMed ID: 15870547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
    Thompson SG; Fechtrup C; Squire E; Heyse U; Breithardt G; van de Loo JC; Kienast J
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):357-62. PubMed ID: 8630659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic value of protein C activity, erythrocyte aggregation and membrane fluidity in transmural myocardial infarction.
    Sargento L; Saldanha C; Monteiro J; Perdigão C; e Silva JM
    Thromb Haemost; 2005 Aug; 94(2):380-8. PubMed ID: 16113829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.
    Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H; Philippou H; Lane DA; Morrison CE
    Br J Haematol; 1997 Jun; 97(4):785-97. PubMed ID: 9217177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.
    Yusuf S; Flather M; Pogue J; Hunt D; Varigos J; Piegas L; Avezum A; Anderson J; Keltai M; Budaj A; Fox K; Ceremuzynski L
    Lancet; 1998 Aug; 352(9127):507-14. PubMed ID: 9716054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.
    van Oijen MG; Claessen BE; Clappers N; van Schaik A; Laheij RJ; Jansen JB; Peters WH; Verheugt FW
    Am J Cardiol; 2008 Jul; 102(2):135-9. PubMed ID: 18602509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke.
    Haapaniemi E; Tatlisumak T; Soinne L; Syrjälä M; Kaste M
    Acta Neurol Scand; 2002 Feb; 105(2):107-14. PubMed ID: 11903120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest.
    Figueras J; Monasterio Y; Lidón RM; Nieto E; Soler-Soler J
    J Am Coll Cardiol; 2000 Dec; 36(7):2036-43. PubMed ID: 11127437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome.
    Fiotti N; Di Chiara A; Altamura N; Miccio M; Fioretti P; Guarnieri G; Giansante C
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):247-55. PubMed ID: 11943939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.
    Foss-Nieradko B; Stepnowska M; Piotrowicz R
    Kardiol Pol; 2012; 70(6):591-7. PubMed ID: 22718378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Sozu T; Terashima M; Michishita I;
    J Atheroscler Thromb; 2013; 20(9):717-25. PubMed ID: 23748166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.
    Fox KA; Poole-Wilson PA; Henderson RA; Clayton TC; Chamberlain DA; Shaw TR; Wheatley DJ; Pocock SJ;
    Lancet; 2002 Sep; 360(9335):743-51. PubMed ID: 12241831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.
    Vonica A; Văgăonescu T; Cristea A; Stăncioiu N
    Med Interne; 1990; 28(4):311-7. PubMed ID: 2100876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
    Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.